Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In-House Recombinant Hepatitis B Vaccine vs Engerix-B in Indonesian Population
NCT05482295Phase 3Not yet recruiting
- Sponsor
- Bio Farma
- Start
- Sep 2025
- Primary completion
- May 2026
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of recombinant hepatitis B vaccine Bio Farma in hepatitis B (HBV), sponsored by Bio Farma. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
recombinant hepatitis B vaccine Bio Farma
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT05482295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05482295.